The global pharma grade synthetic camphor market is on the verge of substantial expansion, with forecasts predicting a Compound Annual Growth Rate (CAGR) of 4.2% from 2022 to 2028. This growth trajectory is expected to drive the market value to an impressive USD 532.0 million by 2028, a significant increase from the USD 415.4 million reported in 2022.
The forecasted growth reflects the increasing demand for high-quality synthetic camphor in pharmaceutical applications, driven by its essential role in various therapeutic and medicinal products. The market’s expansion is also attributed to the growing adoption of synthetic camphor in consumer healthcare products, as well as advancements in manufacturing technologies that enhance product quality and efficiency.
Industry experts attribute this robust growth to several factors, including rising investments in research and development, increasing awareness of the benefits of synthetic camphor, and a growing emphasis on high-purity pharmaceutical ingredients. Additionally, the global trend towards sustainable and eco-friendly production processes is expected to further boost the demand for pharma grade synthetic camphor.
“The projected growth of the pharma grade synthetic camphor market underscores the sector’s significant role in the pharmaceutical industry,” said FMI. “As we approach 2028, we anticipate continued innovation and advancement, driving the market to new heights and enhancing the quality and efficacy of pharmaceutical products globally.”
As the market evolves, stakeholders are advised to stay informed about emerging trends and technological advancements to leverage growth opportunities and remain competitive in this dynamic sector.
Key Takeaways: Pharma Grade Synthetic Camphor Market Growth
- The global pharma grade synthetic camphor market is projected to grow at a CAGR of 4.2% from 2022 to 2028, reaching USD 532.0 million by 2028.
- The U.S. leads the North American market due to high product value and profit margins, while Germany dominates the European market with its robust healthcare infrastructure and high prevalence of influenza.
- India commands over 55% of the market share, driven by a high incidence of influenza and market accessibility, while China holds around 13.1% of the market, with expectations of rapid expansion due to rising influenza cases and low vaccination rates.
- The market is also experiencing growing demand for alternative medicines to treat influenza and related illnesses, particularly in high-risk populations like children and the elderly.
- Increased awareness and accessibility of over-the-counter (OTC) products for self-medication are contributing to market growth.
High Demand for Pharma Grade Synthetic Camphor: Uncover the Trends and Insights with Our Detailed Report!
Competitive Landscape:
Manufacturers and integrators are actively expanding their consumer base across various regions by increasing over-the-counter purchases and enhancing product availability through multiple sales channels. Key industry players are also focusing on expanding their brands and technology in emerging markets through strategic partnerships and collaborations to strengthen their market presence.
For instance:
- In January 2017, Merck acquired BioControl Systems Inc., enhancing its position in the food safety testing sector.
- In August 2016, Merck inaugurated a new pharmaceuticals manufacturing plant in Nantong, China, further supporting its expansion in the Chinese market.
Key Companies Profiled:
- Merck KGaA
- Oriental Aromatics Limited
- Saptagir Camphor Limited
- Mangalam Organics Limited
- Nippon Fine Chemical Co., Ltd.
- Rochem International, Inc.
- Spectrum Chemical Mfg. Corp.
- Aldon Corporation
- Prinova Group LLC
- Fengchen Group Co., Ltd.
Market Segmentation:
By Formulation Type:
- Topical
- Inhalation
By Application:
- Respiratory Disorders
- Muscular Rheumatism
- Counterirritant and Antipruritic
- Others
By Distribution Channels:
- Conventional B2B (Tenders, Direct Procurement, Wholesalers & Distributors)
- Online B2B (Internal Channel, External Channel)
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- APECJ
- Japan
- China
- Middle East & Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
